Vertex Pharmaceuticals Inc. buy Barclays PLC
Start price
06.02.24
/
50%
€387.70
Target price
06.02.25
€439.24
Performance (%)
11.44%
Price
15:13
€432.05
Summary
This prediction is currently active. The prediction currently has a performance of 11.44%. This prediction currently runs until 06.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | -0.679% | -0.679% |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
Comments by Barclays_PLC for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Barclays PLC from $446.00 to $472.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.60
11.12.23
11.12.23
€385.41
11.12.24
11.12.24
33.09%
15:13
15:13